Braskem (BRKM5) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Q2 2026 saw recurring EBITDA reach $1.043 billion, driven by higher international spreads from Middle East supply shocks and positive tax credits in Brazil, with all segments showing improved results.
Net revenue for 2Q2026 was R$21,715 million, up 21.6% year-over-year, and net profit was R$3,323 million, reversing a prior loss.
The company focused on maintaining production, capturing market opportunities, and advancing Alagoas remediation, with 99.9% of relocations and compensation completed.
Strategic priorities for H2 2026 include capital structure optimization, operational excellence, and disciplined capital allocation amid ongoing restructuring talks.
Material uncertainty remains regarding going concern due to negative equity, high leverage, and ongoing debt restructuring.
Financial highlights
Consolidated recurring EBITDA reached $1.043 billion (24% margin), up from $876 million in 1Q26 and $192 million in 2Q25.
Net revenue was US$4.3 billion, up 46% sequentially and 37% year-over-year.
Net income attributable to shareholders was US$664 million, a turnaround from a loss of US$45 million in 2Q25.
Operating cash generation was $385 million, with recurring cash generation at $210 million; cash and cash equivalents at quarter-end were R$3,931 million.
Positive impacts included $150 million in PIS/COFINS credits and recovery of vessel demurrage credits.
Outlook and guidance
Consultants forecast normalization of spreads in H2 2026 and 2027, with potential volatility from ongoing geopolitical risks.
The petrochemical cycle remains structurally challenged by global overcapacity and moderate demand.
Management continues to pursue capital structure reorganization and liquidity restoration, but outcomes depend on negotiations.
Regulatory measures, such as antidumping duties and sector incentives, are expected to partially mitigate competitive pressures.
The company expects a recovery in sales before margin recovery, but visibility remains limited due to market volatility.
Latest events from Braskem
- EBITDA rose 76% sequentially, but leverage, cash burn, and legal risks remain high.BRKM5
Q1 2026 - Recurring EBITDA fell 49% and net loss reached R$10,961m amid high leverage and industry downturn.BRKM5
Q4 2025 - EBITDA surged 104% sequentially, but net loss and high leverage persisted amid legal and market headwinds.BRKM5
Q3 2025 - EBITDA plunged 67%, leverage hit 10.59x, and legal, market, and cash flow risks remain.BRKM5
Q2 2025 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 2024 - EBITDA hit a two-year high on margin gains, but legal and currency risks remain.BRKM5
Q3 2024 - EBITDA surged 39–46%, but net loss widened on currency impacts; liquidity remains strong.BRKM5
Q2 2024 - EBITDA surged 121% to US$224M, but Alagoas-related risks remain significant.BRKM5
Q1 2025 - EBITDA up 46% to US$1.1B, but FX losses led to a net loss; strong liquidity and green focus.BRKM5
Q4 2024